University of Michigan/Rogel Cancer Center — Ann Arbor, Michigan

University of Michigan/Rogel Cancer Center is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Michigan/Rogel Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma.

Sponsors: Emory University.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan/Rogel Cancer Center?

University of Michigan/Rogel Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan/Rogel Cancer Center conducted?

University of Michigan/Rogel Cancer Center has 1 clinical trials on record. Their work covers Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma.

Is University of Michigan/Rogel Cancer Center accredited by Crixeo Health?

University of Michigan/Rogel Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan/Rogel Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.